{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:49:05Z","timestamp":1782398945818,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Resistance to anti-PD-1 immunotherapy remains a critical challenge in colorectal cancer (CRC). However, the functional role of S100A14 in CRC remains controversial regarding its oncogenic status and impact on immunotherapy response. Here, integrating single-cell RNA sequencing and tissue microarray analysis, we definitively identify S100A14 as an oncogenic driver of immunotherapy resistance. High S100A14 expression correlates with poor prognosis and an immunosuppressive \u201ccold\u201d tumor phenotype. Mechanistically, S100A14 directly binds UPF1, a core nonsense-mediated mRNA decay (NMD) factor, promoting its ubiquitination-mediated degradation. This impairs the decay of non-canonical NF-\u03baB transcripts (MAP3K14, NFKB2, RELB), causing constitutive pathway activation and PD-L1 upregulation. In co-culture assays, S100A14-overexpressing cells directly suppressed CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell cytotoxicity by downregulating GZMB and induced exhaustion via PD-1 upregulation. In syngeneic mouse models, S100A14 overexpression accelerated hepatic metastasis and conferred anti-PD-1 resistance by suppressing GZMB\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell infiltration and promoting Treg recruitment. Notably, restoring UPF1 expression reversed malignant phenotypes in vitro and rescued S100A14-mediated immune evasion in co-culture models. Collectively, we define the S100A14-UPF1-non-canonical NF-\u03baB axis as a actionable mechanism driving immune evasion in CRC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09032-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:06:07Z","timestamp":1782389167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["S100A14 promotes colorectal cancer progression and anti-PD-1 resistance via UPF1-mediated activation of the non-canonical NF-\u03baB signaling"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-090X","authenticated-orcid":false,"given":"Li","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-5579","authenticated-orcid":false,"given":"Xinglong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8631-2192","authenticated-orcid":false,"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0161-435X","authenticated-orcid":false,"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"9032_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"9032_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713\u201332.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9032_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"},{"key":"9032_CR4","doi-asserted-by":"publisher","first-page":"e240029","DOI":"10.6004\/jnccn.2024.0029","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, Chang G, Chen YJ, Ciombor KK, et al. Colon cancer, version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22:e240029.","journal-title":"J Natl Compr Canc Netw"},{"key":"9032_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, Chang G, Chen YJ, Ciombor KK, et al. NCCN Guidelines\u00ae Insights: rectal cancer, version 3.2024. J Natl Compr Canc Netw. 2024;22:366\u201375.","journal-title":"J Natl Compr Canc Netw"},{"key":"9032_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","volume":"23","author":"LA Diaz Jr","year":"2022","unstructured":"Diaz LA Jr, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022;23:659\u201370.","journal-title":"Lancet Oncol"},{"key":"9032_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33:637\u201368.","journal-title":"Int J Biochem Cell Biol"},{"key":"9032_CR8","first-page":"89","volume":"4","author":"H Chen","year":"2014","unstructured":"Chen H, Xu C, Jin Q, Liu Z. S100 protein family in human cancer. Am J Cancer Res. 2014;4:89\u2013115.","journal-title":"Am J Cancer Res"},{"key":"9032_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/1759-7714.12654","volume":"9","author":"F Ding","year":"2018","unstructured":"Ding F, Wang D, Li XK, Yang L, Liu HY, Cui W, et al. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma. Thorac Cancer. 2018;9:827\u201335.","journal-title":"Thorac Cancer"},{"key":"9032_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s43046-020-00048-y","volume":"32","author":"N Al-Ashkar","year":"2020","unstructured":"Al-Ashkar N, Zetoune AB. S100A14 serum level and its correlation with prognostic factors in breast cancer. J Egypt Natl Canc Inst. 2020;32:37.","journal-title":"J Egypt Natl Canc Inst"},{"key":"9032_CR11","doi-asserted-by":"publisher","first-page":"e16356","DOI":"10.1097\/MD.0000000000016356","volume":"98","author":"L Hu","year":"2019","unstructured":"Hu L, Kong F, Pan Y. Prognostic and clinicopathological significance of S100A14 expression in cancer patients: a meta-analysis. Medicine. 2019;98:e16356.","journal-title":"Medicine"},{"key":"9032_CR12","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.7314\/APJCP.2013.14.6.3831","volume":"14","author":"FT Zhao","year":"2013","unstructured":"Zhao FT, Jia ZS, Yang Q, Song L, Jiang XJ. S100A14 promotes the growth and metastasis of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14:3831\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"9032_CR13","first-page":"45","volume":"23","author":"HY Wang","year":"2010","unstructured":"Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, Gu J, et al. Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep. 2010;23:45\u201352.","journal-title":"Oncol Rep"},{"key":"9032_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.21873\/invivo.11777","volume":"34","author":"A Diamantopoulou","year":"2020","unstructured":"Diamantopoulou A, Mantas D, Kostakis ID, Agrogiannis G, Garoufalia Z, Kavantzas N, et al. A clinicopathological analysis of S100A14 expression in colorectal cancer. In Vivo. 2020;34:321\u201330.","journal-title":"In Vivo"},{"key":"9032_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li J, Wu C, Hu H, Qin G, Wu X, Bai F, et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell. 2023;41:1152\u201369.e1157.","journal-title":"Cancer Cell"},{"key":"9032_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342\u20138.","journal-title":"Nature"},{"key":"9032_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semcancer.2012.03.006","volume":"22","author":"D Spano","year":"2012","unstructured":"Spano D, Heck C, De Antonellis P, Christofori G, Zollo M. Molecular networks that regulate cancer metastasis. Semin Cancer Biol. 2012;22:234\u201349.","journal-title":"Semin Cancer Biol"},{"key":"9032_CR18","doi-asserted-by":"publisher","first-page":"17109","DOI":"10.1074\/jbc.M111.326975","volume":"287","author":"H Chen","year":"2012","unstructured":"Chen H, Yuan Y, Zhang C, Luo A, Ding F, Ma J, et al. Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation. J Biol Chem. 2012;287:17109\u201319.","journal-title":"J Biol Chem"},{"key":"9032_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.521","volume":"5","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ma F, Li Z, Li Y, Sun X, Song M, et al. NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2\/PD-L1-dependent manner. MedComm. 2024;5:e521.","journal-title":"MedComm"},{"key":"9032_CR20","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1172\/JCI86508","volume":"126","author":"J Lu","year":"2016","unstructured":"Lu J, Plank TD, Su F, Shi X, Liu C, Ji Y, et al. The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors. J Clin Invest. 2016;126:3058\u201362.","journal-title":"J Clin Invest"},{"key":"9032_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"9032_CR22","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41594-018-0132-7","volume":"25","author":"T Kurosaki","year":"2018","unstructured":"Kurosaki T, Miyoshi K, Myers JR, Maquat LE. NMD-degradome sequencing reveals ribosome-bound intermediates with 3\u2019-end non-templated nucleotides. Nat Struct Mol Biol. 2018;25:940\u201350.","journal-title":"Nat Struct Mol Biol"},{"key":"9032_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.annonc.2024.03.009","volume":"35","author":"M Ambrosini","year":"2024","unstructured":"Ambrosini M, Rousseau B, Manca P, Artz O, Marabelle A, Andr\u00e9 T, et al. Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Ann Oncol. 2024;35:643\u201355.","journal-title":"Ann Oncol"},{"key":"9032_CR24","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/cancers12123850","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Rajput A, Jin N, Wang J. Mechanisms of immunosuppression in colorectal cancer. Cancers. 2020;12:3850.","journal-title":"Cancers"},{"key":"9032_CR25","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.18632\/oncotarget.26861","volume":"10","author":"S Basnet","year":"2019","unstructured":"Basnet S, Sharma S, DE Costea, Sapkota D. Expression profile and functional role of S100A14 in human cancer. Oncotarget. 2019;10:2996\u20133012.","journal-title":"Oncotarget"},{"key":"9032_CR26","first-page":"1484","volume":"5","author":"X Wang","year":"2015","unstructured":"Wang X, Yang J, Qian J, Liu Z, Chen H, Cui Z. S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells. Am J Cancer Res. 2015;5:1484\u201395.","journal-title":"Am J Cancer Res"},{"key":"9032_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.pan.2021.01.011","volume":"21","author":"H Zhu","year":"2021","unstructured":"Zhu H, Gao W, Li X, Yu L, Luo D, Liu Y, et al. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Pancreatology. 2021;21:589\u201398.","journal-title":"Pancreatology"},{"key":"9032_CR28","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1021\/pr4004294","volume":"12","author":"CH Ko","year":"2013","unstructured":"Ko CH, Cheng CF, Lai CP, Tzu TH, Chiu CW, Lin MW, et al. Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry. J Proteome Res. 2013;12:3573\u201385.","journal-title":"J Proteome Res"},{"key":"9032_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401590","volume":"11","author":"CN Wong","year":"2024","unstructured":"Wong CN, Zhang Y, Ru B, Wang S, Zhou H, Lin J, et al. Identification and characterization of metastasis-initiating cells in ESCC in a multi-timepoint pulmonary metastasis mouse model. Adv Sci. 2024;11:e2401590.","journal-title":"Adv Sci"},{"key":"9032_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09927-0","volume":"22","author":"C Wang","year":"2022","unstructured":"Wang C, Chen Y, Xinpeng Y, Xu R, Song J, Ruze R, et al. Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer. BMC Cancer. 2022;22:879.","journal-title":"BMC Cancer"},{"key":"9032_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101080","volume":"74","author":"G Che","year":"2024","unstructured":"Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, et al. Circumventing drug resistance in gastric cancer: a spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics. Drug Resist Updat. 2024;74:101080.","journal-title":"Drug Resist Updat"},{"key":"9032_CR32","doi-asserted-by":"publisher","first-page":"106735","DOI":"10.1016\/j.intimp.2020.106735","volume":"86","author":"J Liu","year":"2020","unstructured":"Liu J, Chen X, Jiang Y, Cheng W. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy\/chemotherapy in endometrial cancer. Int Immunopharmacol. 2020;86:106735.","journal-title":"Int Immunopharmacol"},{"key":"9032_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes L, Li F, Wu M, Luo T, Hammarstr\u00f6m K, Torell E, et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633:137\u201346.","journal-title":"Nature"},{"key":"9032_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.14715\/cmb\/2024.70.11.20","volume":"70","author":"S Rasool","year":"2024","unstructured":"Rasool S, Hussein Z, Ali H, Al Ismaeel Q, Al-Mahmoodi H, Yalda M, et al. The emerging role of S100A4 and S100A14 proteins in colorectal cancer progression. Cell Mol Biol. 2024;70:134\u201343.","journal-title":"Cell Mol Biol"},{"key":"9032_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3892\/or.2023.8656","volume":"50","author":"J Zhang","year":"2023","unstructured":"Zhang J, Li C, Sun L, Sun D, Zhao T. P53\u2011microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions. Oncol Rep. 2023;50:219.","journal-title":"Oncol Rep"},{"key":"9032_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.986","volume":"12","author":"HY Min","year":"2022","unstructured":"Min HY, Cho J, Sim JY, Boo HJ, Lee JS, Lee SB, et al. S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancer. Clin Transl Med. 2022;12:e986.","journal-title":"Clin Transl Med"},{"key":"9032_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13046-022-02243-2","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhu S, Du Y, Xu F, Sun W, Xu Z, et al. RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion. J Exp Clin Cancer Res. 2022;41:66.","journal-title":"J Exp Clin Cancer Res"},{"key":"9032_CR38","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.4049\/jimmunol.1400833","volume":"193","author":"J Yu","year":"2014","unstructured":"Yu J, Wang Y, Yan F, Zhang P, Li H, Zhao H, et al. Noncanonical NF-\u03baB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer. J Immunol. 2014;193:2574\u201386.","journal-title":"J Immunol"},{"key":"9032_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217692","volume":"620","author":"M Kundu","year":"2025","unstructured":"Kundu M, Greer YE, Lobanov A, Ridnour L, Donahue RN, Ng Y, et al. TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells. Cancer Lett. 2025;620:217692.","journal-title":"Cancer Lett"},{"key":"9032_CR40","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, et al. Intratumoral Fusobacterium nucleatum recruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion. Cancer Res. 2025;85:1819\u201341.","journal-title":"Cancer Res"},{"key":"9032_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/path.4784","volume":"240","author":"W Shi","year":"2016","unstructured":"Shi W, Ye Z, Zhuang L, Li Y, Shuai W, Zuo Z, et al. Olfactomedin 1 negatively regulates NF-\u03baB signalling and suppresses the growth and metastasis of colorectal cancer cells. J Pathol. 2016;240:352\u201365.","journal-title":"J Pathol"},{"key":"9032_CR42","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1038\/s41388-018-0363-4","volume":"37","author":"Y Tao","year":"2018","unstructured":"Tao Y, Liu Z, Hou Y, Wang S, Liu S, Jiang Y, et al. Alternative NF-\u03baB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3. Oncogene. 2018;37:5887\u2013900.","journal-title":"Oncogene"},{"key":"9032_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0677-x","volume":"18","author":"X Zhou","year":"2018","unstructured":"Zhou X, Shan Z, Yang H, Xu J, Li W, Guo F. RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells. Cancer Cell Int. 2018;18:181.","journal-title":"Cancer Cell Int"},{"key":"9032_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/path.4527","volume":"236","author":"MD Burkitt","year":"2015","unstructured":"Burkitt MD, Hanedi AF, Duckworth CA, Williams JM, Tang JM, O\u2019Reilly LA, et al. NF-\u03baB1, NF-\u03baB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL\/6 mice. J Pathol. 2015;236:326\u201336.","journal-title":"J Pathol"},{"key":"9032_CR45","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.devcel.2022.04.010","volume":"57","author":"RH Moy","year":"2022","unstructured":"Moy RH, Nguyen A, Loo JM, Yamaguchi N, Kajba CM, Santhanam B, et al. Functional genetic screen identifies ITPR3\/calcium\/RELB axis as a driver of colorectal cancer metastatic liver colonization. Dev Cell. 2022;57:1146\u201359.e1147.","journal-title":"Dev Cell"},{"key":"9032_CR46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41417-022-00456-3","volume":"29","author":"Y Li","year":"2022","unstructured":"Li Y, Hu J, Guo D, Ma W, Zhang X, Zhang Z, et al. LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway. Cancer Gene Ther. 2022;29:1373\u201383.","journal-title":"Cancer Gene Ther"},{"key":"9032_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01491-y","volume":"23","author":"S Liu","year":"2021","unstructured":"Liu S, Chen W, Hu H, Zhang T, Wu T, Li X, et al. Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Breast Cancer Res. 2021;23:115.","journal-title":"Breast Cancer Res"},{"key":"9032_CR48","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.3802\/jgo.2025.36.e127","volume":"36","author":"G Abudourexiti","year":"2025","unstructured":"Abudourexiti G, Zhang J, Abuduxikuer G. UPF1 inhibits cervical cancer cell migration and invasion by regulating nonsense-mediated decay of BMP6 and lncRNA WAKMAR2. J Gynecol Oncol. 2025;36:e127.","journal-title":"J Gynecol Oncol"},{"key":"9032_CR49","first-page":"10657","volume":"23","author":"CL Pei","year":"2019","unstructured":"Pei CL, Fei KL, Yuan XY, Gong XJ. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1. Eur Rev Med Pharmacol Sci. 2019;23:10657\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9032_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43148-z","volume":"9","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Li Y, Wang N, Li X, Zheng J, Ge L. UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1. Sci Rep. 2019;9:6652.","journal-title":"Sci Rep"},{"key":"9032_CR51","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1159\/000479994","volume":"42","author":"L Li","year":"2017","unstructured":"Li L, Geng Y, Feng R, Zhu Q, Miao B, Cao J, et al. The human RNA surveillance factor UPF1 modulates gastric cancer progression by targeting long non-coding RNA MALAT1. Cell Physiol Biochem. 2017;42:2194\u2013206.","journal-title":"Cell Physiol Biochem"},{"key":"9032_CR52","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1042\/CS20181061","volume":"133","author":"X Xie","year":"2019","unstructured":"Xie X, Lin J, Liu J, Huang M, Zhong Y, Liang B, et al. A novel lncRNA NR4A1AS up-regulates orphan nuclear receptor NR4A1 expression by blocking UPF1-mediated mRNA destabilization in colorectal cancer. Clin Sci. 2019;133:1457\u201373.","journal-title":"Clin Sci"},{"key":"9032_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7150\/ijms.27359","volume":"16","author":"X Wang","year":"2019","unstructured":"Wang X, Lai Q, He J, Li Q, Ding J, Lan Z, et al. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-\u03b2\/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 2019;16:51\u201359.","journal-title":"Int J Med Sci"},{"key":"9032_CR54","doi-asserted-by":"publisher","first-page":"137135","DOI":"10.1016\/j.ijbiomac.2024.137135","volume":"282","author":"J Luo","year":"2024","unstructured":"Luo J, Xu S, Wang J, He L, Li Z. Circular RNA circWBSCR22 facilitates colorectal cancer metastasis by enhancing CHD4\u2019s protein stability. Int J Biol Macromol. 2024;282:137135.","journal-title":"Int J Biol Macromol"},{"key":"9032_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216935","volume":"593","author":"F Yao","year":"2024","unstructured":"Yao F, Zhou S, Zhang R, Chen Y, Huang W, Yu K, et al. CRISPR\/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma. Cancer Lett. 2024;593:216935.","journal-title":"Cancer Lett"},{"key":"9032_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115919","volume":"44","author":"S Zhu","year":"2025","unstructured":"Zhu S, Bai Y, Zhang D, Huang C, Qian X, Li P, et al. Inhibiting UPF1 methylation enhances tumor immunotherapy sensitivity by reducing nonsense-mediated mRNA decay. Cell Rep. 2025;44:115919.","journal-title":"Cell Rep"},{"key":"9032_CR57","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1038\/s41388-020-1363-8","volume":"39","author":"DF Meng","year":"2020","unstructured":"Meng DF, Sun R, Liu GY, Peng LX, Zheng LS, Xie P, et al. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1. Oncogene. 2020;39:5307\u201322.","journal-title":"Oncogene"},{"key":"9032_CR58","doi-asserted-by":"publisher","first-page":"110180","DOI":"10.1016\/j.cellsig.2021.110180","volume":"89","author":"R Sarkar","year":"2022","unstructured":"Sarkar R, Banerjee S, Mukherjee A, Chawla-Sarkar M. Rotaviral nonstructural protein 5 (NSP5) promotes proteasomal degradation of up-frameshift protein 1 (UPF1), a principal mediator of nonsense-mediated mRNA decay (NMD) pathway, to facilitate infection. Cell Signal. 2022;89:110180.","journal-title":"Cell Signal"},{"key":"9032_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1130562","volume":"14","author":"D A\u011fag\u00fcnd\u00fcz","year":"2023","unstructured":"A\u011fag\u00fcnd\u00fcz D, Cocozza E, Cemali \u00d6, Bayaz\u0131t AD, Nan\u00ec MF, Cerqua I, et al. Understanding the role of the gut microbiome in gastrointestinal cancer: A review. Front Pharmacol. 2023;14:1130562.","journal-title":"Front Pharmacol"},{"key":"9032_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1667500","volume":"16","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhou M, Luo F, Feng S, Tan Y, Wang Q, et al. Cryptotanshinone targets tumor-immune-microbiome axis to suppress colorectal cancer. Front Pharmacol. 2025;16:1667500.","journal-title":"Front Pharmacol"},{"key":"9032_CR61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41522-026-00919-7","volume":"12","author":"X Wei","year":"2026","unstructured":"Wei X, Huang H, Wang F, Tan P, Wang Z, Qiu X, et al. Modulation of gut microbiota and its metabolite Equol by Huaier granule suppresses hepatocellular carcinoma via the gut-liver axis. NPJ Biofilms Microbiomes. 2026;12:54.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"9032_CR62","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-025-01268-6","volume":"24","author":"R Hajjar","year":"2026","unstructured":"Hajjar R, Mars RAT, Kashyap PC. Harnessing the microbiome for cancer therapy. Nat Rev Microbiol. 2026;24:392\u2013407.","journal-title":"Nat Rev Microbiol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09032-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:04:24Z","timestamp":1782396264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09032-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9032"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09032-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"597"}}